AB0953 Psaid-12 can be used to determine the anti-tnf treatment decision in the psoriatic arthritis...
AB0953 Psaid-12 can be used to determine the anti-tnf treatment decision in the psoriatic arthritis registry
About this item
Full title
Author / Creator
Kalyoncu, U. , Kiraz, S. , Apras Bilgen, S. , Karadag, O. , Akdogan, A. , Kilic, L. , Erden, A. , Armagan, B. , Sari, A. and Ertenli, I.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundPsoriatic Arthritis Impact of Disease (PsAID-12) score has 12 questions and each question has its own weight. PsAID-12 is developed to be used in daily practice. However, in the daily practice, there has been no information on the utilisation of determining the response of the biological DMARD treatment.ObjectivesThe assessment of utilisa...
Alternative Titles
Full title
AB0953 Psaid-12 can be used to determine the anti-tnf treatment decision in the psoriatic arthritis registry
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071220535
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071220535
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.5155
